textbook:
  'Cellular Metabolism and Cancer: Nature or Nurture? - Exploring the Intersection of Metabolism and Cancer":':
    chapters:
    - '- Chapter 1: Introduction to the Course:':
        sections:
        - '- Section: 1.1 Overview of the Course:':
            subsections:
            - 1.1a Course Goals
            - 1.1b Course Materials
            - 1.1c Course Schedule
        - '- Section: 1.2 Learning Objectives:':
            subsections:
            - 1.2a Understanding Cancer Metabolism
            - 1.2b Exploring the Intersection of Metabolism and Cancer
            - 1.2c Applying Knowledge to Real-World Scenarios
        - '- Section: 1.3 Course Structure and Requirements:':
            subsections:
            - 1.3a Coursework and Assignments
            - 1.3b Grading Policy
            - 1.3c Course Policies and Expectations
    - '- Chapter 2: An Introduction to Cancer Metabolism: The Warburg Effect:':
        sections:
        - '- Section: 2.1 Warburg Effect and Tumor Metabolism:':
            subsections:
            - 2.1a Definition of the Warburg Effect
            - 2.1b Role of the Warburg Effect in Tumor Metabolism
            - 2.1c Implications for Cancer Treatment
        - '- Section: 2.2 Changes in Carbohydrate Metabolism:':
            subsections:
            - 2.2a Normal Carbohydrate Metabolism
            - 2.2b Alterations in Carbohydrate Metabolism in Cancer
            - 2.2c Impact on Tumor Growth and Survival
        - '- Section: 2.3 Lactic Acid and Co-combing Power:':
            subsections:
            - 2.3a Production of Lactic Acid in Cancer Cells
            - 2.3b Role of Lactic Acid in Tumor Metabolism
            - 2.3c Co-combing Power and Energy Production
    - '- Chapter 3: Role of Mitochondrial Function in Tumor Cell Growth:':
        sections:
        - '- Section: 3.1 Mitochondria and Cancer Cells:':
            subsections:
            - 3.1a Role of Mitochondria in Normal Cells
            - 3.1b Changes in Mitochondrial Function in Cancer Cells
            - 3.1c Impact on Tumor Cell Growth and Survival
        - '- Section: 3.2 Energy Production and ATP Synthesis:':
            subsections:
            - 3.2a Normal Energy Production and ATP Synthesis
            - 3.2b Alterations in Energy Production in Cancer Cells
            - 3.2c Role of ATP in Tumor Cell Growth
        - '- Section: 3.3 Mitochondrial Dysfunction and Tumor Progression:':
            subsections:
            - 3.3a Causes of Mitochondrial Dysfunction in Cancer Cells
            - 3.3b Impact of Mitochondrial Dysfunction on Tumor Progression
            - 3.3c Potential Therapeutic Targets
    - '- Chapter 4: Amino Acid Metabolism:':
        sections:
        - '- Section: 4.1 Amino Acids and Cancer Cell Growth:':
            subsections:
            - 4.1a Role of Amino Acids in Normal Cell Growth
            - 4.1b Changes in Amino Acid Metabolism in Cancer Cells
            - 4.1c Impact on Tumor Cell Growth and Survival
        - '- Section: 4.2 Metabolic Alterations in Amino Acid Pathways:':
            subsections:
            - 4.2a Normal Amino Acid Metabolic Pathways
            - 4.2b Alterations in Amino Acid Pathways in Cancer Cells
            - 4.2c Role in Tumor Metabolism and Growth
        - '- Section: 4.3 Role of Amino Acids in Tumor Microenvironment:':
            subsections:
            - 4.3a Tumor Microenvironment and Amino Acid Availability
            - 4.3b Impact of Amino Acid Availability on Tumor Growth
            - 4.3c Therapeutic Implications
    - '- Chapter 5: Nucleotide and Lipid Metabolism:':
        sections:
        - '- Section: 5.1 Nucleotide Metabolism in Cancer Cells:':
            subsections:
            - 5.1a Normal Nucleotide Metabolism
            - 5.1b Changes in Nucleotide Metabolism in Cancer Cells
            - 5.1c Impact on Tumor Cell Growth and Survival
        - '- Section: 5.2 Lipid Metabolism and Tumor Progression:':
            subsections:
            - 5.2a Normal Lipid Metabolism
            - 5.2b Changes in Lipid Metabolism in Cancer Cells
            - 5.2c Role in Tumor Progression
        - '- Section: 5.3 Lipid Signaling and Cancer Development:':
            subsections:
            - 5.3a Role of Lipid Signaling in Normal Cells
            - 5.3b Alterations in Lipid Signaling in Cancer Cells
            - 5.3c Impact on Cancer Development
    - '- Chapter 6: Mutations in Isocitrate Dehydrogenase and the Discovery of a Neomorphic Activity:':
        sections:
        - '- Section: 6.1 Isocitrate Dehydrogenase Mutations in Cancer:':
            subsections:
            - 6.1a Normal Function of Isocitrate Dehydrogenase
            - 6.1b Mutations in Isocitrate Dehydrogenase in Cancer Cells
            - 6.1c Impact on Tumor Metabolism and Growth
        - '- Section: 6.2 Neomorphic Activity of Mutant Isocitrate Dehydrogenase:':
            subsections:
            - 6.2a Definition of Neomorphic Activity
            - 6.2b Neomorphic Activity of Mutant Isocitrate Dehydrogenase
            - 6.2c Role in Tumor Metabolism and Growth
        - '- Section: 6.3 Metabolic Consequences of Mutant Isocitrate Dehydrogenase:':
            subsections:
            - 6.3a Changes in Metabolic Pathways Due to Mutant Isocitrate Dehydrogenase
            - 6.3b Impact on Tumor Cell Growth and Survival
            - 6.3c Potential Therapeutic Targets
    - '- Chapter 7: 2-hydroxyglutarate: The First Oncometabolite?:':
        sections:
        - '- Section: 7.1 Oncometabolites and Cancer Development:':
            subsections:
            - 7.1a Definition of Oncometabolites
            - 7.1b Role of 2-hydroxyglutarate as an Oncometabolite
            - 7.1c Impact on Cancer Development
        - '- Section: 7.2 Role of 2-hydroxyglutarate in Tumorigenesis:':
            subsections:
            - 7.2a Production of 2-hydroxyglutarate in Cancer Cells
            - 7.2b Role of 2-hydroxyglutarate in Tumor Metabolism
            - 7.2c Impact on Tumor Growth and Survival
        - '- Section: 7.3 Metabolic Effects of 2-hydroxyglutarate Accumulation:':
            subsections:
            - 7.3a Changes in Metabolic Pathways Due to 2-hydroxyglutarate Accumulation
            - 7.3b Impact on Tumor Cell Growth and Survival
            - 7.3c Potential Therapeutic Targets
    - '- Chapter 8: Oncogenes and Metabolism: How Genetic Changes Alter Cancer Metabolism:':
        sections:
        - '- Section: 8.1 Oncogenes and Their Role in Metabolic Reprogramming:':
            subsections:
            - 8.1a Definition of Oncogenes
            - 8.1b Role of Oncogenes in Metabolic Reprogramming of Cancer Cells
            - 8.1c Impact on Tumor Growth and Survival
        - '- Section: 8.2 Genetic Alterations and Altered Metabolic Pathways:':
            subsections:
            - 8.2a Common Genetic Alterations in Cancer Cells
            - 8.2b Impact of Genetic Alterations on Metabolic Pathways
            - 8.2c Role in Tumor Metabolism and Growth
        - '- Section: 8.3 Interplay between Oncogenes and Metabolism in Tumor Growth:':
            subsections:
            - 8.3a Interactions between Oncogenes and Metabolic Pathways
            - 8.3b Role in Tumor Cell Growth and Survival
            - 8.3c Potential Therapeutic Targets
    - '- Chapter 9: Context Matters! How Tissue Environment Alters Cancer Cell Metabolism:':
        sections:
        - '- Section: 9.1 Tissue Microenvironment and Metabolic Adaptations:':
            subsections:
            - 9.1a Role of the Tissue Microenvironment in Normal Cell Metabolism
            - 9.1b Metabolic Adaptations of Cancer Cells to the Tissue Microenvironment
            - 9.1c Impact on Tumor Growth and Survival
        - '- Section: 9.2 Metabolic Heterogeneity in Tumor Microenvironment:':
            subsections:
            - 9.2a Definition of Metabolic Heterogeneity
            - 9.2b Metabolic Heterogeneity in the Tumor Microenvironment
            - 9.2c Role in Tumor Growth and Survival
        - '- Section: 9.3 Metabolic Interactions between Cancer Cells and Stroma:':
            subsections:
            - 9.3a Role of the Stroma in Tumor Metabolism
            - 9.3b Metabolic Interactions between Cancer Cells and Stroma
            - 9.3c Impact on Tumor Growth and Survival
    - '- Chapter 10: Metabolic Interactions of Stroma Cells and Cancer:':
        sections:
        - '- Section: 10.1 Role of Stroma Cells in Tumor Metabolism:':
            subsections:
            - 10.1a Role of Stroma Cells in Normal Tissue Metabolism
            - 10.1b Changes in Stroma Cell Metabolism in Cancer
            - 10.1c Impact on Tumor Growth and Survival
        - '- Section: 10.2 Metabolic Crosstalk between Cancer Cells and Stroma:':
            subsections:
            - 10.2a Definition of Metabolic Crosstalk
            - 10.2b Metabolic Crosstalk between Cancer Cells and Stroma
            - 10.2c Role in Tumor Growth and Survival
        - '- Section: 10.3 Impact of Stroma Metabolism on Tumor Progression:':
            subsections:
            - 10.3a Role of Stroma Metabolism in Normal Tissue Growth
            - 10.3b Impact of Stroma Metabolism on Tumor Progression
            - 10.3c Potential Therapeutic Targets
    - '- Chapter 11: Impact of Diet on Tumor Metabolism and Progression:':
        sections:
        - '- Section: 11.1 Nutritional Factors and Cancer Metabolism:':
            subsections:
            - 11.1a Role of Nutrition in Normal Cell Metabolism
            - 11.1b Impact of Nutritional Factors on Cancer Metabolism
            - 11.1c Role in Tumor Growth and Survival
        - '- Section: 11.2 Diet-induced Metabolic Changes in Tumor Cells:':
            subsections:
            - 11.2a Impact of Diet on Normal Cell Metabolism
            - 11.2b Diet-induced Metabolic Changes in Cancer Cells
            - 11.2c Role in Tumor Growth and Survival
        - '- Section: 11.3 Role of Dietary Components in Tumor Progression:':
            subsections:
            - 11.3a Role of Dietary Components in Normal Cell Growth
            - 11.3b Impact of Dietary Components on Tumor Progression
            - 11.3c Potential Therapeutic Targets
    - '- Chapter 12: Oral Presentations and Final Discussion:':
        sections:
        - '- Section: 12.1 Presentation Guidelines and Requirements:':
            subsections:
            - 12.1a Guidelines for Oral Presentations
            - 12.1b Requirements for Oral Presentations
            - 12.1c Grading Criteria for Oral Presentations
        - '- Section: 12.2 Final Discussion on Course Topics and Conclusions:':
            subsections:
            - 12.2a Review of Course Topics
            - 12.2b Discussion of Course Conclusions
            - 12.2c Future Directions in Cancer Metabolism Research
    - '- Chapter 13: Metabolic Pathways and Cancer Therapeutics:':
        sections:
        - '- Section: 13.1 Targeting Metabolic Pathways for Cancer Treatment:':
            subsections:
            - 13.1a Overview of Metabolic Pathways as Therapeutic Targets
            - 13.1b Current Therapies Targeting Metabolic Pathways
            - 13.1c Challenges and Future Directions
        - '- Section: 13.2 Drug Development for Cancer Metabolism:':
            subsections:
            - 13.2a Process of Drug Development
            - 13.2b Current Drugs Targeting Cancer Metabolism
            - 13.2c Future Directions in Drug Development
        - '- Section: 13.3 Clinical Trials and Cancer Metabolism:':
            subsections:
            - 13.3a Role of Clinical Trials in Cancer Treatment
            - 13.3b Current Clinical Trials Targeting Cancer Metabolism
            - 13.3c Future Directions in Clinical Trials
    - '- Chapter 14: Metabolic Imaging and Cancer Diagnosis:':
        sections:
        - '- Section: 14.1 Role of Metabolic Imaging in Cancer Diagnosis:':
            subsections:
            - 14.1a Overview of Metabolic Imaging
            - 14.1b Current Use of Metabolic Imaging in Cancer Diagnosis
            - 14.1c Future Directions in Metabolic Imaging
        - '- Section: 14.2 Techniques in Metabolic Imaging:':
            subsections:
            - 14.2a Overview of Metabolic Imaging Techniques
            - 14.2b Current Techniques in Metabolic Imaging
            - 14.2c Future Directions in Metabolic Imaging Techniques
        - '- Section: 14.3 Clinical Applications of Metabolic Imaging:':
            subsections:
            - 14.3a Role of Metabolic Imaging in Clinical Practice
            - 14.3b Current Clinical Applications of Metabolic Imaging
            - 14.3c Future Directions in Clinical Applications of Metabolic Imaging
    - '- Chapter 15: Metabolomics and Cancer Research:':
        sections:
        - '- Section: 15.1 Role of Metabolomics in Cancer Research:':
            subsections:
            - 15.1a Overview of Metabolomics
            - 15.1b Current Use of Metabolomics in Cancer Research
            - 15.1c Future Directions in Metabolomics
        - '- Section: 15.2 Techniques in Metabolomics:':
            subsections:
            - 15.2a Overview of Metabolomics Techniques
            - 15.2b Current Techniques in Metabolomics
            - 15.2c Future Directions in Metabolomics Techniques
        - '- Section: 15.3 Clinical Applications of Metabolomics:':
            subsections:
            - 15.3a Role of Metabolomics in Clinical Practice
            - 15.3b Current Clinical Applications of Metabolomics
            - 15.3c Future Directions in Clinical Applications of Metabolomics
    - '- Chapter 16: Metabolic Biomarkers and Cancer Diagnosis:':
        sections:
        - '- Section: 16.1 Role of Metabolic Biomarkers in Cancer Diagnosis:':
            subsections:
            - 16.1a Overview of Metabolic Biomarkers
            - 16.1b Current Use of Metabolic Biomarkers in Cancer Diagnosis
            - 16.1c Future Directions in Metabolic Biomarkers
        - '- Section: 16.2 Techniques in Metabolic Biomarker Discovery:':
            subsections:
            - 16.2a Overview of Metabolic Biomarker Discovery Techniques
            - 16.2b Current Techniques in Metabolic Biomarker Discovery
            - 16.2c Future Directions in Metabolic Biomarker Discovery Techniques
        - '- Section: 16.3 Clinical Applications of Metabolic Biomarkers:':
            subsections:
            - 16.3a Role of Metabolic Biomarkers in Clinical Practice
            - 16.3b Current Clinical Applications of Metabolic Biomarkers
            - 16.3c Future Directions in Clinical Applications of Metabolic Biomarkers
    - '- Chapter 17: Metabolic Syndrome and Cancer Risk:':
        sections:
        - '- Section: 17.1 Role of Metabolic Syndrome in Cancer Risk:':
            subsections:
            - 17.1a Overview of Metabolic Syndrome
            - 17.1b Current Understanding of Metabolic Syndrome and Cancer Risk
            - 17.1c Future Directions in Metabolic Syndrome and Cancer Research
        - '- Section: 17.2 Metabolic Syndrome and Specific Cancer Types:':
            subsections:
            - 17.2a Metabolic Syndrome and Breast Cancer
            - 17.2b Metabolic Syndrome and Colorectal Cancer
            - 17.2c Metabolic Syndrome and Prostate Cancer
        - '- Section: 17.3 Clinical Management of Metabolic Syndrome in Cancer Patients:':
            subsections:
            - 17.3a Role of Clinical Management of Metabolic Syndrome in Cancer Patients
            - 17.3b Current Clinical Management Strategies
            - 17.3c Future Directions in Clinical Management of Metabolic Syndrome
              in Cancer Patients
    - '- Chapter 18: Metabolic Inflammation and Cancer:':
        sections:
        - '- Section: 18.1 Role of Metabolic Inflammation in Cancer:':
            subsections:
            - 18.1a Overview of Metabolic Inflammation
            - 18.1b Current Understanding of Metabolic Inflammation and Cancer
            - 18.1c Future Directions in Metabolic Inflammation and Cancer Research
        - '- Section: 18.2 Metabolic Inflammation and Specific Cancer Types:':
            subsections:
            - 18.2a Metabolic Inflammation and Breast Cancer
            - 18.2b Metabolic Inflammation and Colorectal Cancer
            - 18.2c Metabolic Inflammation and Prostate Cancer
        - '- Section: 18.3 Clinical Management of Metabolic Inflammation in Cancer Patients:':
            subsections:
            - 18.3a Role of Clinical Management of Metabolic Inflammation in Cancer
              Patients
            - 18.3b Current Clinical Management Strategies
            - 18.3c Future Directions in Clinical Management of Metabolic Inflammation
              in Cancer Patients
    - '- Chapter 19: Metabolic Stress and Cancer:':
        sections:
        - '- Section: 19.1 Role of Metabolic Stress in Cancer:':
            subsections:
            - 19.1a Overview of Metabolic Stress
            - 19.1b Current Understanding of Metabolic Stress and Cancer
            - 19.1c Future Directions in Metabolic Stress and Cancer Research
        - '- Section: 19.2 Metabolic Stress and Specific Cancer Types:':
            subsections:
            - 19.2a Metabolic Stress and Breast Cancer
            - 19.2b Metabolic Stress and Colorectal Cancer
            - 19.2c Metabolic Stress and Prostate Cancer
        - '- Section: 19.3 Clinical Management of Metabolic Stress in Cancer Patients:':
            subsections:
            - 19.3a Role of Clinical Management of Metabolic Stress in Cancer Patients
            - 19.3b Current Clinical Management Strategies
            - 19.3c Future Directions in Clinical Management of Metabolic Stress in
              Cancer Patients
    - '- Chapter 20: Future Directions in Cancer Metabolism Research:':
        sections:
        - '- Section: 20.1 Emerging Topics in Cancer Metabolism:':
            subsections:
            - 20.1a Overview of Emerging Topics
            - 20.1b Current Research in Emerging Topics
            - 20.1c Future Directions in Emerging Topics
        - '- Section: 20.2 Challenges in Cancer Metabolism Research:':
            subsections:
            - 20.2a Overview of Current Challenges
            - 20.2b Strategies to Overcome Challenges
            - 20.2c Future Directions in Overcoming Challenges
        - '- Section: 20.3 Opportunities in Cancer Metabolism Research:':
            subsections:
            - 20.3a Overview of Current Opportunities
            - 20.3b Strategies to Leverage Opportunities
            - 20.3c Future Directions in Leveraging Opportunities
